Upregulation of SUMO2 promotes GLUT1 degradation through SUMOylation and ubiquitination of GLUT1, which regulates the AMPK-mTOR pathway by inhibiting glycolysis, ultimately resulting in proliferation and metastasis of NPC (Fig. 8F). The gene discussed is SLC2A1; the disease is nasopharyngeal carcinoma.